- Report
- July 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- May 2024
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2023
- 282 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- January 2022
- 81 Pages
Global
From €3200EUR$3,592USD£2,775GBP
- Report
- March 2022
- 180 Pages
Global
From €3298EUR$3,456USD£2,764GBP
The Bioprocessing Material market is a subset of the biotechnology industry that focuses on the production of materials used in bioprocessing. These materials are used in the manufacture of biopharmaceuticals, such as vaccines, antibodies, and other therapeutic proteins. The market is driven by the increasing demand for biopharmaceuticals, as well as the need for more efficient and cost-effective production methods. The market is also driven by advances in bioprocessing technology, such as cell culture and fermentation, which have enabled the production of higher quality biopharmaceuticals.
Some of the major players in the Bioprocessing Material market include Merck KGaA, Thermo Fisher Scientific, Sartorius AG, GE Healthcare, and Lonza Group. Other companies in the market include Eppendorf AG, Danaher Corporation, and Corning Incorporated. Show Less Read more